Skip to main content
Livermore
Livermore
ZHEN

Cambridge Advisors Inc.

SEC CIK
0001633695
Latest filing
Jul 16, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Cambridge Advisors Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
6,470
Value
$587.1K
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by Cambridge Advisors Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,470$587.1K0.1%−250−3.7%ReducedHolders
Q1 20266,720$689.9K0.1%−25−0.4%ReducedHolders
Q4 20256,745$845.1K0.2%00.0%UnchangedHolders
Q3 20256,745$903.4K0.2%−122−1.8%ReducedHolders
Q2 20256,867$934.0K0.2%+22+0.3%AddedHolders
Q1 20256,845$908.0K0.2%00.0%UnchangedHolders
Q4 20246,845$774.2K0.2%−250−3.5%ReducedHolders
Q3 20247,095$808.9K0.2%−150−2.1%ReducedHolders
Q2 20247,245$752.8K0.2%−25−0.3%ReducedHolders
Q1 20247,270$826.3K0.2%−475−6.1%ReducedHolders
Q4 20237,745$852.5K0.2%−200−2.5%ReducedHolders
Q3 20237,945$769.5K0.2%00.0%UnchangedHolders
Q2 20237,945$866.2K0.2%−745−8.6%ReducedHolders
Q1 20238,690$879.9K0.2%00.0%UnchangedHolders
Q4 20228,690$954.1K0.3%−200−2.2%ReducedHolders
Q3 20228,890$860.0K0.2%00.0%UnchangedHolders
Q2 20228,890$966.0K0.3%−145−1.6%ReducedHolders
Q1 20229,035$1.07M0.3%−50−0.6%ReducedHolders
Q4 20219,085$1.28M0.3%00.0%UnchangedHolders
Q3 20219,085$1.07M0.3%−700−7.2%ReducedHolders
Q2 20219,785$1.13M0.3%−305−3.0%ReducedHolders
Q1 202110,090$1.21M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.